How can we ensure that cheap-to-produce medicines are accessible also to the poor?

What is it about?

Instead of rewarding new pharmaceuticals with monopoly patents, which often lead to prices that are thousands of times higher than cost of production, we should reward them according to the health gains actually achieved with them, counting all beneficiaries equally. This system would provide ample incentives for innovation and would ensure much wider utilization of effective medicines.

Featured Image

Why is it important?

Millions of people suffer and even die every year because they cannot afford medicines that can be mass-produced for pennies.

Perspectives